Eric VIVIER has been selected to appear on the 2015 edition of the world’s highly cited researcher list. Published every year by Thomson Reuters, a major multinational mass media and information firm, this list honors the authors of the most cited publications by the scientific community.
Jonathan EWBANK is the winner of the 2015 Fondation de la Recherche Médicale (FRM) Lucien Tartois Prize (in Immunology, Oncology ou Virology). Jonathan Ewbank, director of research at Inserm heads the group, "Innate immunity in C. elegans" at the Centre d'Immunologie de Marseille-Luminy, in close collaboration with Nathalie Pujol.
Bertrand Nadel, new Director for the PACA CancéropôleWednesday, April 15 last, the General Meeting of GIP Cancéropôle PACA, chaired by Professor Yvon Berland, has appointed a new Director, Dr Bertrand Nadel, group leader to CIML. He succeeds Professor Christian Chabannon, hematologist, Head of Cellular Therapy Center at the Institut Paoli-Calmettes.
Two new ERC (Consolidator Grants) for the CIML awarded to Sophie Ugolini and Marc Bajénoff. For their project: NEURIMMUNE- Neural regulation of immunity and STROMA- Immunobiology of lymphoid stromal cells.
ERC Consolidator Grants are designed to support researchers at the stage at which they are consolidating their own independent research team or programme.
Michael Sieweke awarded Einstein BIH fellowship by the Berlin Institute of Health. The prestigious German award “Einstein BIH Visiting Fellow” recognizes international top researchers with the aim to foster closer interactions with the research landscape in Berlin and make the fellows’ expertise available to the local scientific community. More informations...
The team led by Michael Sieweke at the Centre d'immunologie de Marseille Luminy (Université Aix-Marseille 2 / CNRS / INSERM) has proved that this is the case by achieving the ex vivo regeneration for several months of macrophages, specialized cells in the immune system. Published in Science on November 6, 2009, this discovery could be applied to other cell types. This research enables a clearer understanding of the mechanisms underlying cell differentiation, but above all raises many hopes for potential therapeutic applications. More information...
François Kourilsky, co-founder of the CIML, died on May 31st 2014
World-class physician and immunologist, his work on tumor biology and the major histocompatibility complex contributed significantly to what many historians of science refer to today as an immunological revolution. François Kourilsky together with Michel Fougereau founded the CIML in 1976; he was general director of the CNRS from 1988 to 1994 (more to come soon online).
